Quick Answer
COSCIENS Biopharma Inc. reported Research And Development Expense of $2.95 million for the year ending 2025.
- COSCIENS Biopharma Inc. showed a decrease of -64.5% in Research And Development Expense from 2024 to 2025.
- This data is from COSCIENS Biopharma Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), COSCIENS Biopharma Inc.'s Research And Development Expense has declined by 82.9%.
- Historical annual values: Fiscal year 2025: $2.95 million | Fiscal year 2024: $8.30 million | Fiscal year 2023: $2.04 million | Fiscal year 2022: $1.37 million | Fiscal year 2021: $6.57 million | Fiscal year 2020: $1.51 million | Fiscal year 2019: $1.84 million | Fiscal year 2018: $2.93 million | Fiscal year 2017: $10.70 million | Fiscal year 2016: $16.50 million | Fiscal year 2015: $17.23 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: